Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers

A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer. Scientists have demonstrated the potential efficacy of this approach a preclinical study.

from All Top News -- ScienceDaily https://ift.tt/EIbHhtP

Comments